Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temazepam for Sleep and Respiratory Function in COPD
NCT00245661Phase 3Completed
- Sponsor
- Rijnstate
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of temazepam in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Rijnstate. Primary endpoints: transcutaneous PCO2 at 1 week, transcutaneous PO2 at 1 week and 1 more. Started Oct 2005; status: completed.
02
Drugs
temazepam
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00245661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245661.